Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 16/20 | 0.67 |
| ▸ | DDB1 | Q16531 | 9/20 | 0.53 |
| ▸ | BTK | Q06187 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.45 |
| ▸ | IKZF2 | Q9UKS7 | 1/20 | 0.45 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22737760 | 1.00 | CRBN (0.67) | CRBNDDB1BTKALDH1A1CHRM2 | |
| SCHEMBL22737357 | 0.98 | CRBN (0.70) | CRBNDDB1BTKALDH1A1CHRM2 | |
| SCHEMBL22737359 | 0.98 | CRBN (0.70) | CRBNDDB1BTKALDH1A1CHRM2 | |
| SCHEMBL22738044 | 0.94 | CRBN (0.65) | CRBNDDB1BTKALDH1A1CHRM2 | |
| SCHEMBL22738043 | 0.94 | CRBN (0.65) | CRBNDDB1BTKALDH1A1CHRM2 | |
| SCHEMBL22737960 | 0.90 | CRBN (0.72) | CRBNDDB1BTKALDH1A1CHRM2 | |
| SCHEMBL25949579 | 0.89 | CRBN (0.61) | CRBNDDB1BTKALDH1A1CHRM2 | |
| SCHEMBL25939463 | 0.88 | CRBN (0.76) | CRBNDDB1BTKALDH1A1CHRM2 | |
| SCHEMBL24827976 | 0.86 | CRBN (0.72) | CRBNDDB1BTKALDH1A1CHRM2 | |
| SCHEMBL22737594 | 0.85 | CRBN (0.71) | CRBNDDB1BTKALDH1A1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022007824-A1 | COMPOUND HAVING BTK KINASE DEGRADING ACTIVITY, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREFOR | 四川海思科制药有限公司 | 2022-01-13 | — | — | WO | disclosed |
| WO-2020239103-A1 | BTK INHIBITOR RING DERIVATIVE, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL APPLICATION THEREOF | 四川海思科制药有限公司 | 2020-12-03 | — | — | WO | disclosed |